9 minutes | Jun 25th 2018

154 - first catheter-based systems for vascular access in hemodialysis; PCS499 in necrobiosis lipoidica; automated insulin delivery for younger patients; first implantable continuous glucose monitoring system.

June 25, 2018  Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com  0:44 FDA permits marketing of first catheter-based systems used to create vascular access for hemodialysis patients https://www.prnewswire.com/news-releases/fda-permits-marketing-of-first-catheter-based-systems-used-to-create-vascular-access-for-hemodialysis-patients-300670882.html  3:06 Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The Food And Drug Administration (FDA) https://www.prnewswire.com/news-releases/processa-pharmaceuticals-receives-orphan-designation-status-for-pcs499-in-necrobiosis-lipoidica-from-the-food-and-drug-administration-fda-300670592.html  4:05 FDA approves automated insulin delivery and monitoring system for use in younger pediatric patients https://www.prnewswire.com/news-releases/fda-approves-automated-insulin-delivery-and-monitoring-system-for-use-in-younger-pediatric-patients-300670538.html  5:36 FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes https://www.prnewswire.com/news-releases/fda-approves-first-continuous-glucose-monitoring-system-with-a-fully-implantable-glucose-sensor-and-compatible-mobile-app-for-adults-with-diabetes-300670465.html Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com. Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/ 
Play
Like
Play Next
Mark
Played
Share